ACADIA Pharmaceuticals Inc. vs Wheaton Precious Metals Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Wheaton Precious Metals Corp trades at $136.69 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 12× ACADIA Pharmaceuticals Inc.'s market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | WPM | |
|---|---|---|
Market Cap | $5.07B | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $29.41 | $165.72 |
52-Week Low | $20.06 | $91.02 |
Enterprise Value | $4.19B | $62.82B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →